Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol

Ben Khaled, Najib; Seidensticker, Max; Ricke, Jens; Mayerle, Julia; Oehrle, Bettina; Roessler, Daniel; Teupser, Daniel; Ehmer, Ursula; Bitzer, Michael; Waldschmidt, Dirk; Fuchs, Martin; Reuken, Philipp A.; Lange, Christian M.; Wege, Henning; Kandulski, Arne; Dechene, Alexander; Venerito, Marino; Berres, Marie-Luise; Luedde, Tom; Kubisch, Ilja; Reiter, Florian P.; De Toni, Enrico N.

Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol

Autor(en):

Ben Khaled, Najib; Seidensticker, Max; Ricke, Jens; Mayerle, Julia; Oehrle, Bettina; Roessler, Daniel; Teupser, Daniel; Ehmer, Ursula; Bitzer, Michael; Waldschmidt, Dirk; Fuchs, Martin; Reuken, Philipp A.; Lange, Christian M.; Wege, Henning; Kandulski, Arne; Dechene, Alexander; Venerito, Marino; Berres, Marie-Luise; Luedde, Tom; Kubisch, Ilja; Reiter, Florian P.; De Toni, Enrico N.

Tübinger Autor(en):

Bitzer, Michael

Erschienen in:

Future Oncology (2022), Bd. 18, H. 12, S. 1423-1435

Verlagsangabe:

Future Medicine Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.2217/fon-2021-1261

ISSN:

1479-6694